GRANULES INDIA LTD. - Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Download	< Back
18 Oct 2021
Recipt of approval from US FDA for the ANDA filed by GPI for Dofetilide Capsules, 125 mcg, 250 mcg, and 500 mcg.
View all announcements for GRANULES INDIA LTD.	Source: BSE India

ALL MONEYWIZ PAGES

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us